Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi Arabia

BACKGROUND: In 2015, multiple myeloma (MM) represented 1% of all cancers and about 5% of hematologic malignancies in Saudi cancer registry. We conducted this large study because only small pilot studies have examined MM outcomes after autologous stem-cell transplantation (ASCT). The standard therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdrabou, Ahmed Kotb, Sharif, Fahad Al, Fakih, Riad El, Hashmi, Shahrukh, Khafaga, Yasser Mohamed, Alhayli, Saud, Zahrani, Hazaa Al, Ahmed, Syed, Fraih, Feras Al, Shaheen, Marwan, Rasheed, Walid, Chaudhri, Naeem Arshad, Mohareb, Fahad Al, Khalil, Hala, Aljurf, Mahmoud, Hanbali, Amr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380276/
https://www.ncbi.nlm.nih.gov/pubmed/34420396
http://dx.doi.org/10.5144/0256-4947.2021.198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380276/
https://www.ncbi.nlm.nih.gov/pubmed/34420396
http://dx.doi.org/10.5144/0256-4947.2021.198

Ejemplares similares